SMMT - サミット・セラピュ―ティクス (Summit Therapeutics plc)

SMMTのニュース

   Is Summit Therapeutics (SMMT) Stock Outpacing Its Medical Peers This Year?  2020/03/24 15:30:05 Zacks Investment Research
Is (SMMT) Outperforming Other Medical Stocks This Year?
   AIM Delisting Reminder  2020/02/11 10:00:00 GlobeNewswire
Summit Therapeutics plc(“Summit Therapeutics” or the “Company”) AIM Delisting Reminder Oxford, UK, and Cambridge, MA, US, 11 February 2020 - Summit…
   Summit Therapeutics raises $40m, completes board restructuring  2019/12/24 10:11:09 Share Cast
Antibiotic innovation company Summit Therapeutics raised $50.0m on Tuesday by way of a subscription and placing of new ordinary shares and warrants.
   Completion of $50 million Fundraising and Directorate Change  2019/12/24 08:30:00 GlobeNewswire
Summit Therapeutics plc(“Summit Therapeutics” or the “Company”) Completion of $50 million Subscription and Placing and Directorate Changes Oxford, UK,…
   Timetable Update  2019/12/19 07:00:00 GlobeNewswire
Summit Therapeutics plc(“Summit Therapeutics” or the “Company”) Timetable update for the proposed Subscription and Placing Oxford, UK, and Cambridge,…
   Summit Therapeutics raises $40m, completes board restructuring  2019/12/24 10:11:09 Share Cast
Antibiotic innovation company Summit Therapeutics raised $50.0m on Tuesday by way of a subscription and placing of new ordinary shares and warrants.
   Completion of $50 million Fundraising and Directorate Change  2019/12/24 08:30:00 GlobeNewswire
Summit Therapeutics plc(“Summit Therapeutics” or the “Company”) Completion of $50 million Subscription and Placing and Directorate Changes Oxford, UK,…
   Timetable Update  2019/12/19 07:00:00 GlobeNewswire
Summit Therapeutics plc(“Summit Therapeutics” or the “Company”) Timetable update for the proposed Subscription and Placing Oxford, UK, and Cambridge,…
   Summit Therapeutics raising $50m, plans to delist from AIM  2019/12/06 15:57:49 Share Cast
Antibiotic innovation company Summit Therapeutics announced a proposed fundraising of about $50m through a subscription and placing of new ordinary shares and warrants to existing investors on Friday, which would be subject to certain shareholder approvals being obtained and certain customary closing conditions being satisfied.
   Summit Therapeutics : Recognises C. difficile Awareness Month | MarketScreener  2019/11/04 13:55:17 MarketScreener
Summit Therapeutics plc Summit Therapeutics Recognises C. difficile Awareness Month Company to Highlight… | November 4, 2019
   Summit Therapeutics reports data for DDS-04 for Enterobacteriaceae at ECCMID 2019  2019-04-15
Summit Therapeutics (NASDAQ: SMMT ) presents in vivo proof of concept data for the DDS-04 series of new mechanism antibiotics targeting Enterobacteriaceae atECCMID 2019 in Amsterdam. More news on: Summit Therapeutics, Healthcare stocks news, Read more …

calendar